Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | NPY2R | P49146 | 4/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.60 |
| ▸ | BACE1 | P56817 | 8/20 | 0.56 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.56 |
| ▸ | CTSD | P07339 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30331385 | 0.97 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30483946 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30496421 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL29512422 | 0.93 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL8813021 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| Thymopentin SCHEMBL44001 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL8815384 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| Thymopentin SCHEMBL989519 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5R | |
| Thymopentin SCHEMBL7498758 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30331711 | 0.93 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024232825-A1 | MAGNETICALLY RESPONSIVE HYDROGELS AND USES THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2024-11-14 | — | — | WO | disclosed |